診療グループ

感染症グループ業績

グループ詳細へ戻る

業績

2025年
Original Article
  • Hyodo A, Seki F, Fukuda K, Tashiro K, Kitai Y, Akahori Y, Watabe H, Katoh H, Osaki R, Takaya D, Kawashita N, Fukuhara H, Ikegame S, Yoshikawa T, Eunsil P, Morikawa S, Yamaguchi R, Lee B, Maenaka K, Shirai T, Fukuzawa K, Tanaka S, Takeda M

    Evolutionary and structural basis of SLAMF1 utilization in morbilliviruses-Implications for host range and cross-species transmission.

    PLoS Pathog 21(6): e1012990, 2025Pubmed

2024年
Original Article
  • Ogo N, Ikegame S, Hotta T, Kan-O K, Yoneshima Y, Shiraishi Y, Tsubouchi K, Tanaka K, Okamoto I

    The Utility and Limitations of Universal Polymerase Chain Reaction Screening for SARS-CoV-2 During Hospital Admission.

    Cureus 16(5): e61470, 2024Pubmed

  • Katahira K, Gotoh Y, Kasama K, Yoshimura D, Itoh T, Shimauchi C, Tajiri A, Hayashi T

    Mobile genetic element-driven genomic changes in a community-associated methicillin-resistant Staphylococcus aureus clone during its transmission in regional community outbreak in Japan.

    Microb Genom 10(7): 001272, 2024Pubmed

2023年
Original Article
  • Ikegame S, Carmichael JC, Wells H, Furler O'Brien RL, Acklin JA, Chiu HP, Oguntuyo KY, Cox RM, Patel AR, Kowdle S, Stevens CS, Eckley M, Zhan S, Lim JK, Veit EC, Evans MJ, Hashiguchi T, Durigon E, Schountz T, Epstein JH, Plemper RK, Daszak P, Anthony SJ, Lee B

    Metagenomics-enabled reverse-genetics assembly and characterization of myotis bat morbillivirus.

    Nat Microbiol 8(6): 1108-1122, 2023Pubmed

  • Yamashita S, Ikegame S, Nakatomi K, Sakurai Y, Shuto H, Sato N, Mizoguchi Y, Uehara M, Nakashima N, Okamoto I, Koto H

    Respiratory Virus Infections during the COVID-19 Pandemic Revealed by Multiplex PCR Testing in Japan.

    Microbiol Spectr 11(2): e0416222, 2023Pubmed

グループ詳細へ戻る